The vitamin D receptor and T cell function

Frontiers in Immunology

Volumn 4, Issue JUN, 2013, Pages

  Kongsbak, Martin ^a   Levring, Trine B ^a   Geisler, Carsten ^a   von Essen, Marina Rode ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Activity; Expression; Signaling; T cell function; Vitamin D; Vitamin D receptor

Indexed keywords

CALCIFEDIOL; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN KINASE C; PROTEIN KINASE ZAP 70; VITAMIN D RECEPTOR;

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VITAMIN D RESPONSIVE ELEMENT;

EID: 84883776612     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00148     Document Type: Review

References (115)

1. Achiron, A., Grotto, I., Balicer, R., Magalashvili, D., Feldman, A., and Gurevich, M. (2010). Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis. Neurobiol. Dis. 38, 201-209. doi:10.1016/j.nbd.2009.12.029
2. Adorini, L., and Penna, G. (2009). Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 70, 345-352. doi:10.1016/j.humimm.2009.01.016
3. Adorini, L., Penna, G., Giarratana, N., and Uskokovic, M. (2003). Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 88, 227-233. doi:10.1002/jcb.10340
4. Alroy, I., Towers, T. L., and Freedman, L. P. (1995). Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15, 5789-5799.
5. Araki, M., Kondo, T., Gumperz, J. E., Brenner, M. B., Miyake, S., and Yamamura, T. (2003). Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15, 279-288. doi:10.1093/intimm/dxg029
6. Arnaud, J., and Constans, J. (1993). Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum. Genet. 92, 183-188. doi:10.1007/BF00219689
7. Baeke, F., Korf, H., Overbergh, L., van, E. E., Verstuyf, A., Gysemans, C., et al. (2010). Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem. Mol. Biol. 121, 221-227. doi:10.1016/j.jsbmb.2010.03.037
8. Baeke, F., Korf, H., Overbergh, L., Verstuyf, A., Thorrez, L., Van, L. L., et al. (2011). The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 186, 132-142. doi:10.4049/jimmunol.1000695
9. Bendelac, A., Bonneville, M., and Kearney, J. F. (2001). Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1, 177-186. doi:10.1038/35105052
10. Bezbradica, J. S., Gordy, L. E., Stanic, A. K., Dragovic, S., Hill, T., Hawiger, J., et al. (2006). Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 25, 487-497. doi:10.1016/j.immuni.2006.06.017
11. Bhalla, A. K., Amento, E. P., Clemens, T. L., Holick, M. F., and Krane, S. M. (1983). Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57, 1308-1310. doi:10.1210/jcem-57-6-1308
12. Bouillon, R., Carmeliet, G., Verlinden, L., van, E. E., Verstuyf, A., Luderer, H. F., et al. (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776. doi:10.1210/er.2008-0004
13. Bruce, D., and Cantorna, M. T. (2011). Intrinsic requirement for the vitamin D receptor in the development of CD8alphaalpha-expressing T cells. J. Immunol. 186, 2819-2825. doi:10.4049/jimmunol.1003444
14. Bruce, D., Yu, S., Ooi, J. H., and Cantorna, M. T. (2011). Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23, 519-528. doi:10.1093/intimm/dxr045
15. Cannell, J. J., Vieth, R., Umhau, J. C., Holick, M. F., Grant, W. B., Madronich, S., et al. (2006). Epidemic influenza and vitamin D. Epidemiol. Infect. 134, 1129-1140. doi:10.1017/S0950268806007175
16. Cantrell, D. A., and Smith, K. A. (1984). The interleukin-2 T-cell system: a new cell growth model. Science 224, 1312-1316. doi:10.1126/science.6427923
17. Cassani, B., Villablanca, E. J., De, C. J., Wang, S., and Mora, J. R. (2012). Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol. Aspects Med. 33, 63-76. doi:10.1016/j.mam.2011.11.001
18. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.
19. Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., et al. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580. doi:10.1016/S0092-8674(00)80516-4
20. Cheroutre, H. (2004). Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu. Rev. Immunol. 22, 217-246. doi:10.1146/annurev.immunol.22.012703.104522
21. Chighizola, C., and Meroni, P. L. (2012). The role of environmental estrogens and autoimmunity. Autoimmun. Rev. 11, A493-A501. doi:10.1016/j.autrev.2011.11.027
22. Chun, R. F., Lauridsen, A. L., Suon, L., Zella, L. A., Pike, J. W., Modlin, R. L., et al. (2010). Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 95, 3368-3376. doi:10.1210/jc.2010-0195
23. Correale, J., Ysrraelit, M. C., and Gaitan, M. I. (2009). Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132, 1146-1160. doi:10.1093/brain/awp033
24. Coughlan, C. A., Chotirmall, S. H., Renwick, J., Hassan, T., Low, T. B., Bergsson, G., et al. (2012). The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am. J. Respir. Crit. Care Med. 186, 999-1007. doi:10.1164/rccm.201203-0478OC
25. Edfeldt, K., Liu, P. T., Chun, R., Fabri, M., Schenk, M., Wheelwright, M., et al. (2010). T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 22593-22598. doi:10.1073/pnas.1011624108
26. Ericsson, P. O., Orchansky, P. L., Carlow, D. A., and Teh, H. S. (1996). Differential activation of phospholipase C-gamma 1 and mitogen-activated protein kinase in naive and antigen-primed CD4 T cells by the peptide/MHC ligand. J. Immunol. 156, 2045-2053.
27. Feldman, D., Pike, J. W., and Adams, J. S. (2011). Vitamin D, 3rd Edn. Philadelphia: Elsevier.
28. Feldman, D., Pike, J. W., and Gloreieux, F. (2005). Vitamin D, 2nd Edn. Philadelphia: Elsevier.
29. Forman, B. M., Umesono, K., Chen, J., and Evans, R. M. (1995). Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 19, 541-550. doi:10.1016/0092-8674(95)90075-6
30. Fritsche, J., Mondal, K., Ehrnsperger, A., Andreesen, R., and Kreutz, M. (2003). Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 102, 3314-3316. doi:10.1182/blood-2002-11-3521
31. Froicu, M., and Cantorna, M. T. (2007). Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8:5. doi:10.1186/1471-2172-8-5
32. Froicu, M., Weaver, V., Wynn, T. A., McDowell, M. A., Welsh, J. E., and Cantorna, M. T. (2003). A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17, 2386-2392. doi:10.1210/me.2003-0281
33. Geara, A. S., Castellanos, M. R., Bassil, C., Schuller-Levis, G., Park, E., Smith, M., et al. (2010). Effects of parathyroid hormone on immune function. Clin. Dev. Immunol. 2010:418695. doi:10.1155/2010/418695
34. Geldmeyer-Hilt, K., Heine, G., Hartmann, B., Baumgrass, R., Radbruch, A., and Worm, M. (2011). 1,25-Dihydroxyvitamin D3 impairs NF-kappaB activation in human naive B cells. Biochem. Biophys. Res. Commun. 407, 699-702. doi:10.1016/j.bbrc.2011.03.078
35. Ginde, A. A., Mansbach, J. M., and Camargo, C. A. Jr. (2009). Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 169, 384-390. doi:10.1001/archinternmed.2008.560
36. Gocek, E., Kielbinski, M., and Marcinkowska, E. (2007). Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett. 581, 1751-1757. doi:10.1016/j.febslet.2007.03.055
37. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000). NKT cells: facts, functions and fallacies. Immunol. Today 21, 573-583. doi:10.1016/S0167-5699(00)01735-7
38. Grant, W. B. (2008). Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr. Infect. Dis. J. 27, 853. doi:10.1097/INF.0b013e3181817bc1
39. Greer, R. M., Portelli, S. L., Hung, B. S., Cleghorn, G. J., McMahon, S. K., Batch, J. A., et al. (2012). Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatr. Diabetes 14, 31-41. doi:10.1111/j.1399-5448.2012.00890.x
40. Griffin, M. D., Lutz, W., Phan, V. A., Bachman, L. A., McKean, D. J., and Kumar, R. (2001). Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98, 6800-6805. doi:10.1073/pnas.121172198
41. Hanaoka, B. Y., Peterson, C. A., Horbinski, C., and Crofford, L. J. (2012). Implications of glucocorticoid therapy in idiopathic inflammatory myopathies. Nat. Rev. Rheumatol. 8, 448-457. doi:10.1038/nrrheum.2012.85
42. Haussler, M. R., Whitfield, G. K., Kaneko, I., Haussler, C. A., Hsieh, D., Hsieh, J. C., et al. (2013). Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92, 77-98. doi:10.1007/s00223-012-9619-0
43. Hewison, M., Freeman, L., Hughes, S. V., Evans, K. N., Bland, R., Eliopoulos, A. G., et al. (2003). Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170, 5382-5390.
44. Hogancamp, W. E., Rodriguez, M., and Weinshenker, B. G. (1997). The epidemiology of multiple sclerosis. Mayo Clin. Proc. 72, 871-878. doi:10.4065/72.9.871
45. Hsieh, J. C., Jurutka, P. W., Galligan, M. A., Terpening, C. M., Haussler, C. A., Samuels, D. S., et al. (1991). Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. Proc. Natl. Acad. Sci. U.S.A. 88, 9315-9319. doi:10.1073/pnas.88.20.9315
46. Issa, L. L., Leong, G. M., Barry, J. B., Sutherland, R. L., and Eisman, J. A. (2001). Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk. Endocrinology 142, 1606-1615. doi:10.1210/en.142.4.1606
47. Jeffery, L. E., Wood, A. M., Qureshi, O. S., Hou, T. Z., Gardner, D., Briggs, Z., et al. (2012). Availability of 25-hydroxyvitamin D3 to APCs controls the balance between regulatory and inflammatory T cell responses. J. Immunol. 189, 5155-5164. doi:10.4049/jimmunol.1200786
48. Joseph, R. W., Bayraktar, U. D., Kim, T. K., St John, L. S., Popat, U., Khalili, J., et al. (2012). Vitamin D receptor upregulation in alloreactive human T cells. Hum. Immunol. 73, 693-698. doi:10.1016/j.humimm.2012.04.019
49. Joshi, S., Pantalena, L. C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., et al. (2011). 1,25-Dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31, 3653-3669. doi:10.1128/MCB.05020-11
50. Jurutka, P. W., Hsieh, J. C., Nakajima, S., Haussler, C. A., Whitfield, G. K., and Haussler, M. R. (1996). Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 93, 3519-3524. doi:10.1073/pnas.93.8.3519
51. Khalili, H., Huang, E. S., Ananthakrishnan, A. N., Higuchi, L., Richter, J. M., Fuchs, C. S., et al. (2012). Geographical variation and incidence of inflammatory bowel disease among US women. Gut 61, 1686-1692. doi:10.1136/gutjnl-2011-301574
52. Kim, S., Shevde, N. K., and Pike, J. W. (2005). 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 20, 305-317. doi:10.1359/JBMR.041112
53. Kliewer, S. A., Umesono, K., Mangelsdorf, D. J., and Evans, R. M. (1992). Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355, 446-449. doi:10.1038/355446a0
54. Kreutz, M., Andreesen, R., Krause, S. W., Szabo, A., Ritz, E., and Reichel, H. (1993). 1,25-Dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82, 1300-1307.
55. Krishnan, A. V., and Feldman, D. (1991). Activation of protein kinase-C inhibits vitamin D receptor gene expression. Mol. Endocrinol. 5, 605-612. doi:10.1210/mend-5-4-605
56. Krishnan, A. V., and Feldman, D. (1992). Cyclic adenosine 3',5'-monophosphate up-regulates 1,25-dihydroxyvitamin D3 receptor gene expression and enhances hormone action. Mol. Endocrinol. 6, 198-206. doi:10.1210/me.6.2.198
57. Krutzik, S. R., Hewison, M., Liu, P. T., Robles, J. A., Stenger, S., Adams, J. S., et al. (2008). IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181, 7115-7120.
58. Liu, P. T., Schenk, M., Walker, V. P., Dempsey, P. W., Kanchanapoomi, M., Wheelwright, M., et al. (2009). Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 4:e5810. doi:10.1371/journal.pone.0005810
59. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., et al. (2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773. doi:10.1126/science.1123933
60. Liu, P. T., Wheelwright, M., Teles, R., Komisopoulou, E., Edfeldt, K., Ferguson, B., et al. (2012). MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat. Med. 18, 267-273. doi:10.1038/nm.2584
61. Malloy, P. J., and Feldman, D. (2010). Genetic disorders and defects in vitamin D action. Endocrinol. Metab. Clin. North Am. 39, 333-346. doi:10.1016/j.ecl.2010.02.004
62. Martineau, A. R., Leandro, A. C., Anderson, S. T., Newton, S. M., Wilkinson, K. A., Nicol, M. P., et al. (2010). Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. 35, 1106-1112. doi:10.1183/09031936.00087009
63. Masuyama, H., Brownfield, C. M., St-Arnaud, R., and MacDonald, P. N. (1997a). Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 11, 1507-1517. doi:10.1210/me.11.10.1507
64. Masuyama, H., Jefcoat, S. C. Jr., and MacDonald, P. N. (1997b). The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol. Endocrinol. 11, 218-228. doi:10.1210/me.11.2.218
65. Masuyama, H., and MacDonald, P. N. (1998). Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR. J. Cell. Biochem. 71, 429-440. doi:10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.3.CO;2-G
66. Matsuda, J. L., Mallevaey, T., Scott-Browne, J., and Gapin, L. (2008). CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 20, 358-368. doi:10.1016/j.coi.2008.03.018
67. Mayne, C. G., Spanier, J. A., Relland, L. M., Williams, C. B., and Hayes, C. E. (2011). 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur. J. Immunol. 41, 822-832. doi:10.1002/eji.201040632
68. McDonnell, D. P., Mangelsdorf, D. J., Pike, J. W., Haussler, M. R., and O'Malley, B. W. (1987). Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235, 1214-1217. doi:10.1126/science.3029866
69. Miller, A. V., and Ranatunga, S. K. (2012). Immunotherapies in rheumatologic disorders. Med. Clin. North Am. 96, 475-496. doi:10.1016/j.mcna.2012.04.003
70. Murayama, A., Takeyama, K., Kitanaka, S., Kodera, Y., Kawaguchi, Y., Hosoya, T., et al. (1999). Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 140, 2224-2231. doi:10.1210/en.140.5.2224
71. Nagpal, S., Na, S., and Rathnachalam, R. (2005). Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26, 662-687. doi:10.1210/er.2004-0002
72. Nnoaham, K. E., and Clarke, A. (2008). Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 37, 113-119. doi:10.1093/ije/dym247
73. Oda, Y., Chalkley, R. J., Burlingame, A. L., and Bikle, D. D. (2010). The transcriptional coactivator DRIP/mediator complex is involved in vitamin D receptor function and regulates keratinocyte proliferation and differentiation. J. Invest. Dermatol. 130, 2377-2388. doi:10.1038/jid.2010.148
74. Ohyama, Y., Ozono, K., Uchida, M., Yoshimura, M., Shinki, T., Suda, T., et al. (1996). Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J. Biol. Chem. 271, 30381-30385. doi:10.1074/jbc.271.48.30381
75. Ooi, J. H., Chen, J., and Cantorna, M. T. (2012). Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?. Mol. Aspects Med. 33, 77-82. doi:10.1016/j.mam.2011.10.014
76. Papiha, S. S., and Pal, B. (1985). Gc (vitamin D binding protein) subtypes in rheumatoid arthritis. Hum. Genet. 70, 278-280. doi:10.1007/BF00273457
77. Patel, S. R., Ke, H. Q., Vanholder, R., Koenig, R. J., and Hsu, C. H. (1995). Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J. Clin. Invest. 96, 50-59. doi:10.1172/JCI118061
78. Peelen, E., Knippenberg, S., Muris, A. H., Thewissen, M., Smolders, J., Tervaert, J. W., et al. (2011). Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun. Rev. 10, 733-743. doi:10.1016/j.autrev.2011.05.002
79. Pierrot-Deseilligny, C., and Souberbielle, J. C. (2010). Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?. Brain 133, 1869-1888. doi:10.1093/brain/awq147
80. Pike, J. W. (2011). Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand. Mol. Cell. Endocrinol. 347, 3-10. doi:10.1016/j.mce.2011.05.012
81. Pike, J. W., Meyer, M. B., and Bishop, K. A. (2012). Regulation of target gene expression by the vitamin D receptor - an update on mechanisms. Rev. Endocr. Metab. Disord. 13, 45-55. doi:10.1007/s11154-011-9198-9
82. Pols, H. A., van Leeuwen, J. P., Schilte, J. P., Visser, T. J., and Birkenhager, J. C. (1988). Heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells. Biochem. Biophys. Res. Commun. 156, 588-594. doi:10.1016/S0006-291X(88)80883-0
83. Poussier, P., Ning, T., Banerjee, D., and Julius, M. (2002). A unique subset of self-specific intraintestinal T cells maintains gut integrity. J. Exp. Med. 195, 1491-1497. doi:10.1084/jem.20011793
84. Proal, A. D., Albert, P. J., and Marshall, T. G. (2013). The human microbiome and autoimmunity. Curr. Opin. Rheumatol. 25, 234-240. doi:10.1097/BOR.0b013e32835cedbf
85. Provvedini, D. M., Tsoukas, C. D., Deftos, L. J., and Manolagas, S. C. (1983). 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221, 1181-1183. doi:10.1126/science.6310748
86. Reinhardt, T. A., and Horst, R. L. (1994). Phorbol 12-myristate 13-acetate and 1,25-dihydroxyvitamin D3 regulate 1,25-dihydroxyvitamin D3 receptors synergistically in rat osteosarcoma cells. Mol. Cell. Endocrinol. 101, 159-165. doi:10.1016/0303-7207(94)90230-5
87. Rodriguez, M., Daniels, B., Gunawardene, S., and Robbins, G. K. (2009). High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res. Hum. Retroviruses 25, 9-14. doi:10.1089/aid.2008.0183
88. Rossini, M., Maddali, B. S., La, M. G., Minisola, G., Malavolta, N., Bernini, L., et al. (2010). Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther. 12, R216. doi:10.1186/ar3195
89. Sigmundsdottir, H., Pan, J., Debes, G. F., Alt, C., Habtezion, A., Soler, D., et al. (2007). DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8, 285-293. doi:10.1038/ni1433
90. Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., et al. (2001). Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801-1811. doi:10.1084/jem.194.12.1801
91. Singh, P. K., Doig, C. L., Dhiman, V. K., Turner, B. M., Smiraglia, D. J., and Campbell, M. J. (2012). Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells. J. Steroid Biochem. Mol. Biol. doi:10.1016/j.jsbmb.2012.10.002
92. Sloka, S., Grant, M., and Newhook, L. A. (2010). The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland. Acta Diabetol. 47, 73-78. doi:10.1007/s00592-009-0100-0
93. Smith, K. A. (1988). Interleukin-2: inception, impact, and implications. Science 240, 1169-1176. doi:10.1126/science.3131876
94. Smith, S. J., Green, L. M., Hayes, M. E., and Mawer, E. B. (1999). Prostaglandin E2 regulates vitamin D receptor expression, vitamin D-24-hydroxylase activity and cell proliferation in an adherent human myeloid leukemia cell line (Ad-HL60). Prostaglandins Other Lipid Mediat. 57, 73-85. doi:10.1016/S0090-6980(98)00073-2
95. Song, L. N. (1996). Demonstration of vitamin D receptor expression in a human megakaryoblastic leukemia cell line: regulation of vitamin D receptor mRNA expression and responsiveness by forskolin. J. Steroid Biochem. Mol. Biol. 57, 265-274. doi:10.1016/0960-0760(95)00266-9
96. Spanier, J. A., Nashold, F. E., Olson, J. K., and Hayes, C. E. (2012). The Ifng gene is essential for Vdr gene expression and vitamin D(3)-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model. J. Immunol. 189, 3188-3197. doi:10.4049/jimmunol.1102925
97. Speeckaert, M., Huang, G., Delanghe, J. R., and Taes, Y. E. (2006). Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta 372, 33-42. doi:10.1016/j.cca.2006.03.011
98. Staples, J. A., Ponsonby, A. L., Lim, L. L., and McMichael, A. J. (2003). Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 111, 518-523. doi:10.1289/ehp.5941
99. Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., and Sharma, S. (1998). Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J. Immunol. 160, 209-218.
100. Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., et al. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684. doi:10.1038/42652
101. Towers, T. L., and Freedman, L. P. (1998). Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J. Biol. Chem. 273, 10338-10348. doi:10.1074/jbc.273.17.10338
102. van Leeuwen, J. P., Birkenhager, J. C., Buurman, C. J., van den Bemd, G. J., Bos, M. P., and Pols, H. A. (1992). Bidirectional regulation of the 1,25-dihydroxyvitamin D3 receptor by phorbol ester-activated protein kinase-C in osteoblast-like cells: interaction with adenosine 3',5'-monophosphate-induced up-regulation of the 1,25-dihydroxyvitamin D3 receptor. Endocrinology 130, 2259-2266. doi:10.1210/en.130.4.2259
103. van Leeuwen, J. P., Birkenhager, J. C., Schilte, J. P., Buurman, C. J., and Pols, H. A. (1990). Role of calcium and cAMP in heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor in an osteoblast cell line. Cell Calcium 11, 281-289. doi:10.1016/0143-4160(90)90005-F
104. Vidal, M., Ramana, C. V., and Dusso, A. S. (2002). Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol. Cell. Biol. 22, 2777-2787. doi:10.1128/MCB.22.8.2777-2787.2002
105. Vieira, V. M., Hart, J. E., Webster, T. F., Weinberg, J., Puett, R., Laden, F., et al. (2010). Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses' Health Study. Environ. Health Perspect. 118, 957-961. doi:10.1289/ehp.0901861
106. vom, B. E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., et al. (1996). Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124.
107. von Essen, M. R., Kongsbak, M., Schjerling, P., Olgaard, K., Odum, N., and Geisler, C. (2010). Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat. Immunol. 11, 344-349. doi:10.1038/ni.1851
108. Waterhouse, J. C., Perez, T. H., and Albert, P. J. (2009). Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann. N. Y. Acad. Sci. 1173, 757-765. doi:10.1111/j.1749-6632.2009.04637.x
109. Wood, A. M., Bassford, C., Webster, D., Newby, P., Rajesh, P., Stockley, R. A., et al. (2011). Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 66, 205-210. doi:10.1136/thx.2010.140921
110. Xu, Y., Xie, J., Li, Y., Yue, J., Chen, J., Chunyu, L., et al. (2003). Using a cDNA microarray to study cellular gene expression altered by Mycobacterium tuberculosis. Chin. Med. J. 116, 1070-1073.
111. Yenamandra, S. P., Lundin, A., Arulampalam, V., Yurchenko, M., Pettersson, S., Klein, G., et al. (2009). Expression profile of nuclear receptors upon Epstein-Barr virus induced B cell transformation. Exp. Oncol. 31, 92-96.
112. Yu, S., Bruce, D., Froicu, M., Weaver, V., and Cantorna, M. T. (2008). Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc. Natl. Acad. Sci. U.S.A. 105, 20834-20839. doi:10.1073/pnas.0808700106
113. Yu, S., and Cantorna, M. T. (2008). The vitamin D receptor is required for iNKT cell development. Proc. Natl. Acad. Sci. U.S.A. 105, 5207-5212. doi:10.1073/pnas.0711558105
114. Zella, L. A., Kim, S., Shevde, N. K., and Pike, J. W. (2006). Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 20, 1231-1247. doi:10.1210/me.2006-0015
115. Zella, L. A., Meyer, M. B., Nerenz, R. D., Lee, S. M., Martowicz, M. L., and Pike, J. W. (2010). Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 24, 128-147. doi:10.1210/me.2009-0140